Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
administered the Engerix-B adult dose to a 13 years old patient by accident; administered the Engerix-B adult dose to a 13 years old patient by accident; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental overdose in a 13-year-old patient who received HBV (Engerix B adult) for prophylaxis. On an unknown date, the patient received Engerix B adult. On an unknown date, an unknown time after receiving Engerix B adult, the patient experienced accidental overdose (Verbatim: administered the Engerix-B adult dose to a 13 years old patient by accident) and adult product administered to child (Verbatim: administered the Engerix-B adult dose to a 13 years old patient by accident). The outcome of the accidental overdose and adult product administered to child were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:10-MAR-2025 The reporter reported that one of his/her providers administered the Engerix-B adult dose to a 13 years old patient by accident (6 months ago) and asked if there were there any adverse effects or concerned for the child, which led to accidental overdose and adult product administered to child. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.